Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

Loading...
Thumbnail Image

Authors

Feng, Helian
Gusev, Alexander
Pasaniuc, Bogdan
Wu, Lang
Long, Jirong
Abu-full, Zomoroda
Aittomäki, Kristiina
Andrulis, Irene L.
Anton-Culver, Hoda
Antoniou, Antonis C.

Journal Title

Journal ISSN

Volume Title

Publisher

Wiley

Abstract

Previous transcriptome-wide association studies (TWAS) have identified breast cancer risk genes by integrating data from expression quantitative loci and genome-wide association studies (GWAS), but analyses of breast cancer subtype-specific associations have been limited. In this study, we conducted a TWAS using gene expression data from GTEx and summary statistics from the hitherto largest GWAS meta-analysis conducted for breast cancer overall, and by estrogen receptor subtypes (ER+ and ER−). We further compared associations with ER+ and ER− subtypes, using a case-only TWAS approach. We also conducted multigene conditional analyses in regions with multiple TWAS associations. Two genes, STXBP4 and HIST2H2BA, were specifically associated with ER+ but not with ER− breast cancer. We further identified 30 TWAS-significant genes associated with overall breast cancer risk, including four that were not identified in previous studies. Conditional analyses identified single independent breast-cancer gene in three of six regions harboring multiple TWAS-significant genes. Our study provides new information on breast cancer genetics and biology, particularly about genomic differences between ER+ and ER− breast cancer.

Description

Keywords

Breast cancer subtype, Causal gene, Transcriptome-wide association studies (TWAS), Genome-wide association studies (GWAS)

Sustainable Development Goals

Citation

Feng, H., Gusev, A., Pasaniuc, B. et al. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status. Genetic Epidemiology 2020;44(5): 442-468. doi:10.1002/gepi.22288.